Name
Designations
Role
GMC number
My current role
I have wide experience in the management of kidney (renal) and skin cancers. I have active clinical research interests and I am the Principal Investigator for national and international clinical trials.
I have around 100 peer-reviewed publications and am a member of the National Cancer Research Institute Bladder and Renal Group. I have also advised NICE. I am an author of the 2020 British Association of Dermatologists Squamous cell skin cancer guidelines and the 2021 Basal cell cancer guidelines.
I am chair of the Kidney Cancer UK Accord group, a professional and patient group, which aims to improve management of kidney cancer in the UK.
Previous history
I trained in medicine at St George’s Hospital, London and in oncology at the Royal Marsden Hospital, Hammersmith and Charing Cross Hospital.
I carried out clinical research in HIV related malignancies and completed an MD in angiogenesis related research at Chelsea and Westminster and Charing Cross Hospitals in 1995-8.
Subsequently, I was a locum Consultant and Research Fellow at the Sydney Cancer Centre and Sydney Melanoma Unit, carrying out further laboratory and clinical research.
Memberships and accreditations
- Fellow of Royal College of Physicians
- Fellow of Royal College of Radiologists
- Fellow of Royal Australian and NZ College of Radiologists
Personal interests
I enjoy photography and art.
Publications
-
Lawrence, Nicola J.; Martin, Andrew; Davis, Ian D.; Troon, Simon; Sengupta, Shomik; Hovey, Elizabeth; Coskinas, Xanthi; Kaplan, Richard; Smith, Benjamin; Ritchie, Alastair W. S.; Meade, Angela; Goh, Jeffrey; Gurney, Howard; Harrison, Michelle; Fife, Kate; Eisen, Tim; Blinman, Prunella; Stockler, Martin R. ‘Individualised Predictions of the Survival Benefit Due to Adjuvant Therapy in a Randomised Trial of Sorafenib after Nephrectomy for Localised Renal Cell Carcinoma’.Kidney Cancer, vol. 4, no. 4, pp. 185-195, 2020
-
Keohane SG, Botting J, Budny PG, Dolan OM, Fife K, Harwood CA, Mallipeddi R, Marsden JR, Motley RJ, Newlands C, Proby C, Rembielak A, Slater DN, Smithson JA, Buckley P, Fairbrother P, Hashme M, Mohd Mustapa MF, Exton LS; British Association of Dermatologists’ Clinical Standards Unit. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol. 2020 Nov 4. doi: 10.1111/bjd.19621 PMID: 33150585.
-
Fowler JC, King C, Bryant C, Hall MWJ, Sood R, Ong SH, Earp E, Fernandez-Antoran D, Koeppel J, Dentro SC, Shorthouse D, Durrani A, Fife K, Rytina E, Milne D, Roshan A, Mahububani K, Saeb-Parsy K, Hall BA, Gerstung M, Jones PH. Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body Site. Cancer Discov. 2020 Oct 21. doi: 10.1158/2159-8290.CD-20-1092. Epub ahead of print. PMID: 33087317.
-
Fife K, Bang A. Combined Radiotherapy and New Systemic Therapies - Have We Moved Beyond Palliation? Clin Oncol (R Coll Radiol). 2020 Nov;32(11):758-765. doi: 10.1016/j.clon.2020.07.021. Epub 2020 Aug 27. PMID: 32863071.
-
Hawkins R, Fife K, Hurst M, Wang M, Naicker N, Nolasco S, Eisen T, Matakidou A, Gordon J. Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK. BMC Cancer. 2020 Jul 17;20(1):670. doi: 10.1186/s12885-020-07154-z. PMID: 32680483; PMCID: PMC7368711.